Диссертация (1174250), страница 18
Текст из файла (страница 18)
45. - P. 142-161.90.Sorof, J.M. Evaluation of white-coat hypertension in children:importance of the definitions of normal ambulatory blood pressure and theseverity of casual hypertension / J.M. Sorof // Am. J. Hypertens. - 2001. - Vol.14. - P. 855-860.91.Verdecchia, P. Independent predictors of isolated clinic (white-coat)hypertension / P. Verdecchia, P. Palatini, G. Shillaci.
[et al.] // J. Hypertens. 2001. - Vol. 19. - P. 1015-1020.92.Huang, J.F. The white coat effect during the first hour of ambulatoryblood pressure / J.F. Huang, J. Cao, J.X. Li [et al.] // Zhonghua Xin Xue GuanBing Za Zhi. - 2007. - Vol. 35. - № 8. - P. 723-726.93.Verdecchia, P. Different prognostic impact of 24-hour mean bloodpressure and pulse pressure on stroke and coronary artery disease in essentialhypertension / P. Verdecchia, G.
Schilaci, G. Reboldi [et al.] // Circulation. –2001. – Vol. 103. - P. 2579-2584.94.Hansen, T.W. IDACO Investigators. Prognostic superiority of daytimeambulatory over conventional blood pressure in four populations: a metaanalisis of 7030 individuals / T.W. Hansen, M. Kikuya, L. Thijs [et al.] // J.Hypertens.
- 2007. - Vol. 25. - P. 1554-1564.95.Fagard, R.H. Incidence of cardiovascular events in white-coat, maskedand sustained hypertension versus true normotension: a meta-analysis / R.H.Fagard, V.A. Cornelissen // J. Hypertens. - 2007. - Vol. 25. - P. 2193-2198.96.Ugajin, T. White-coat hypertension as a risk factor for the developmentof home hypertension: the Ohasama study / T.
Ugajin, A. Hozava, T. Ohkudo [etal.] // Arch Int Med. - 2005. - Vol. 165. - P. 1541-1546.97.Mancia, G. Long-term risk of sustained hypertension in white-coat ormasked hypertension / G. Mancia, M. Bombelli, R. Faccetti [et al.] //Hypertension. - 2009. - Vol. 54. - P. 226–232.10898.Bjorklund, K. Different metabolic predictors of white-coat and sustainedhyoertension over a 20-year follow-up period: a population-based study ofelderly men / K. Bjorklund, L. Lind, B. Vessby [et al.] // Circulation.
- 2002. Vol. 106. - P. 63-68.99.Owens, P.E. Is elevation of clinic blood pressure in patients with whitecoat hypertension who have normal ABPM associated with target organchanges? / P.E. Owens, S.P. Lyons, S.A. Rodriguez [et al.] // J. Hum. Hypertens.- 1998. - Vol. 12. - P. 743-748.100.Paraty, G. On behalf of the Study on Ambulatory Monitoring of BloodPressure and Lisinopril Evaluation (SAMPLE) Study Group. Attenuation of the«white coat effect» by antihypertensive treatment and its relationship toregression of target organ damage / G. Paraty, L. Ulian, L. Sampieri [et al.] //Hypertension. - 2000.
- Vol. 35. - P. 614-620.101.Bombelli, M. The Pamela Study: main findings and perspectives / M.Bombelli, E. Toso, M. Peronio [et al.] // Current Hypertension Reports. - 2013. Vol. 15. - № 3. - P. 238-243.102.Dolan, E. Superiority of ambulatory over clinic blood pressuremeasurement in predicting mortality.
The Dublin outcome study / E. Dolan, A.Stanton, L. Thijs [et al.] // Hypertension. - 2005. - Vol. 46. - P. 156-161.103. O`Brien, E. Sleepers v non-sleepers: a new twist in the dipper/non-dipperconcept / E. O`Brien // Hypertension. - 2007. - Vol. 49. - P. 769-770.104. Hermida, R.C. Sleeptime blood pressure: prognostic value and relevanceas a therapeutic target for cardiovascular risk reduction / R.C. Hermida, D.E.Ayala, J.R. Fernandez [et al.] // Chronobiol. Int. - 2013b. - Vol.
30. - P. 68-86.105. Fallo, F. Circadian blood pressure patterns and life stress / F. Fallo, L.Barzon, F. Rabbia [et al.] // Psychother Psychosom. - 2002. - Vol. 71. - № 6. - P.350-356.106. Richardson, S. Meta-analysis of perceived stress and its association withincident coronary heart disease / S. Richardson, J.A. Shaffer, L. Falzon [et al.] //Am J Cardiol.
- 2012. - Vol. 110. - P. 1711-1716.109107. Teague, H. Unraveling Vascular Inflammation: From Immunology toImaging / H. Teague [et al.] // Journal of the American College of Cardiology. 2017. - № 70. - P. 1403-1412.108. Rodriguez-Iturbe, B. Role of the Immune System in Hypertension / B.Rodriguez-Iturbe, H. Pons, R. Johnson // Physiological Reviews. - 2017. - № 97.- P. 1127-1164.109.
Mian, M. Innate immunity in hypertension / M. Mian, P. Paradis, E.Schiffrin // Current Hypertension Reports. - 2014. - № 16. - P. 413.110. Wenzel, U. Immune Mechanisms in Arterial Hypertension / U. Wenzel, J.Turner, C. Krebs [et al.] // Journal of the American Society of Nephrology. 2016. - № 27. - P. 677-686.111. Harrison, D. Vascular inflammatory cells in hypertension / D. Harrison, P.Marvar, J. Titze // Frontiers in Physiology. - 2012. - № 7.
- P.128.112. Lavi, Sh. Role of Nitric Oxide in the Regulation of Cerebral Blood Flowin Humans / Sh. Lavi, R. Egbarya [et al.] // Circulation. - 2003. - Vol. 107. - P.1901-1905.113. Tousoulis, D. The role of nitric oxide on endothelial function / D.Tousoulis, A.M. Kampoli, C. Tentolouris [et al.] // Curr Vasc Pharmacol. 2012.
- Vol. 10. - № 1. - P. 4-18.114. Pattilo, Ch. B. Inorganic nitrite and chronic tissue ischaemia: a noveltherapeutic modality for peripheral vascular diseases / Ch. B. Pattilo, Sh. Bir, V.Rajaram [et al.] // Cardiovasc. Res. - 2011. - Vol. 89. - P. 533-541.115. Щапова, Н.Н. / Дисфункции у больных с гипертонической болезнью/ Н.Н. Щапова, М.Г. Омельяненко, И.К.
Томилова [и др.] // Вестниксовременной клинической медицины. - 2010. - Т. 3. Приложение 1. - С. 209.116. Щапова, Н.Н. Психоэмоциональные факторы и эндотелиальнаядисфункция как предикторы отдаленных событий у пациентов сишемической болезнью сердца и артериальной гипертензией / Н.Н.Щапова, М.Г. Омельяненко [и др.] // Вестник Ивановской медицинскойакадемии. - 2012. - Т. 17. - № 2. - С.
25-29.110117. Morita, K. Expression analysis of psychological stress-associated genes inperipheral blood leukocytes / K. Morita, T. Saito, M. Ohta [et al.] //Neuroscience letters. - 2005. - Vol. 381. - № 1-2. - P. 57-62.118.Black, P.H.
The inflammatory response is an integral part of the stressresponse: Implications for atherosclerosis, insulin resistance, type II diabetesand metabolic syndrome X / P.H. Black // Brain Behav. Immun. - 2003. - Vol.17. - № 5. - P. 350-364.119. Réus, G.Z. The role of inflammation and microglial activation in thepathophysiology of psychiatric disorders / G.Z.
Réus, G.R. Fries, L. Stertz [etal.] // Neuroscience. - 2015. - Vol. 300. - P. 141-154.120. Dantzer, R. From inflammation to sickness and depression: when theimmune system subjugates the brain / R. Dantzer, J.C. O'Connor, G.G. Freund[et al.] // Nat. Rev. Neurosci. - 2008. - Vol. 9. - № 1. - P. 46-56.121. Menard, C.
Social stress induces neurovascular pathology promotingdepression / C. Menard, M.L. Pfau, G.E. Hodes [et al.] // Nat. Neurosci. - 2017.- Vol. 20. - № 12. - P. 1752-1760.122. Takahashi, A. Aggression, social stress, and the immune system inhumans and animal models / A. Takahashi, M.E.
Flanigan, B.S. McEwen [etal.] // Front. Behav. Neurosci. - 2018. - Vol. 12. - P. 56.123. Schlesinger, M. J. Heat shock proteins / M. J. Schlesinger // Journal ofBiological Chemistry. - 1990. - Vol. 265. - № 21. - P. 12111–12114.124. Bernardo, B.C. HSP70: therapeutic potential in acute and chronic cardiacdisease settings / B.C.
Bernardo, K.L. Weeks, N.L. Patterson [et al.] // FutureMed. Chem. - 2016. - Vol. 8. - № 18. - P. 2177–2183.125. Kim, Y.E. Molecular Chaperone Functions in Protein Folding andProteostasis / Y.E. Kim, M.S. Hipp, A. Bracher [et al.] // Annu. Rev. Biochem. 2013. - Vol. 82. - № 1. - P. 323–355.126. Chebotareva, N. Heat shock proteins and kidney disease: perspectives ofHSP therapy / N. Chebotareva, I. Bobkova, E.
Shilov // Cell Stress andChaperones. - 2017. - Vol. 22. - № 3. - P. 319–343.111127. Li, Y. Polymorphisms of heat shock protein 70 genes (HSPA1A,HSPA1B and HSPA1L) and susceptibility of noise-induced hearing loss in aChinese population: A case-control study / Y. Li [et al.] // PLoS One. - 2017. Vol. 12. - № 2. - P.
1-12.128. Gruden, G. ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/macrovascular complications in type 1 diabetes: The EURODIAB Study /Gruden, G. [et al.] // J. Intern. Med. - 2009. - Vol. 266. - № 6. - P. 527–536.129. Орлова, Н.В. Изучение генетической обусловленности артериальнойгипертонии, как фактора риска сердечно-сосудистых заболеваний / Н.В.Орлова, В.Ф. Ситников, И.И. Чукаева [и др.] // Медицинский альманах.
2011. - № 3. - С. 81-84.130. Кох, Н.В. Артериальная гипертония: молекулярно-генетические ифармакогенетические подходы / Н.В. Кох, А.А. Слепухина, Г.И. Лифшиц //Фармакогенетика и Фармакогеномика. - 2015. - № 2. - С. 4-8.131. Ji, L. Association between Polymorphisms in the Renin-AngiotensinAldosterone System Genes and Essential Hypertension in the Han ChinesePopulation / L. Ji, X. Cai, L. Zhang [et al.] // PLoS ONE.
- 2013. - Vol. 8. - № 8.- P. 1.132. Шевченко, О.В. Генетические основы патогенеза эссенциальнойартериальной гипертензии (обзор) / О.В. Шевченко, А.А. Свистунов, В.Б.Бородулин [и др.] // Саратовский научно-медицинский журнал. - 2011. - Т.7. - № 1. - С. 83-87.133.
Zhang, X. Variants of HSPA1A in combination with plasma Hsp70 andanti-Hsp70 antibody levels associated with higher risk of acute coronarysyndrome / X. Zhang [et al.] // Cardiology. - 2011. - Vol. 119. - № 1. - P. 5764.134. Mardan-Nik, M. Association of heat shock protein 70-2 (HSP70-2) genepolymorphism with obesity / M. Mardan-Nik, A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
